SCHEMBL652439

SCHEMBL652439

Clc1cc(I)cnc1Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8127902 0.87 ALDH1A1 (0.34)
SCHEMBL7841178 0.75
SCHEMBL31489841 0.75
SCHEMBL28165954 0.75
SCHEMBL10305653 0.75
SCHEMBL14303161 0.75
SCHEMBL2473751 0.75
SCHEMBL4881353 0.75
SCHEMBL4828775 0.75
SCHEMBL4375559 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4517368-A 2,3-Dichloro-5-iodopyridine and methods of making and using the same THE DOW CHEMICAL COMPANY (US) 1985-05-14 US claimed
EP-0136593-A2 Novel halopyridines and methods of making THE DOW CHEMICAL COMPANY (US) 1985-04-10 EP claimed
US-11332455-B2 α,β-unsaturated amide compound KYOWA KIRIN CO., LTD. (JP) 2022-05-17 US disclosed
US-20210380551-A1 ALPHA,BETA-UNSATURATED AMIDE COMPOUND KYOWA KIRIN CO., LTD. (JP) 2021-12-09 US disclosed
WO-2021138298-A1 MALT1 MODULATORS AND USES THEREOF RHEOS MEDICINES, INC. (US) 2021-07-08 WO disclosed
US-20170204073-A1 COMPOUNDS FOR NONSENSE SUPPRESSION, AND METHODS FOR THEIR USE PTC THERAPEUTICS, INC. (US) 2017-07-20 US disclosed
US-9611230-B2 1,3,4-oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease PTC THERAPEUTICS, INC. (US) 2017-04-04 US disclosed
EP-2494975-A1 Compounds and methods for promoting smoking cessation Research Triangle Institute (US) 2012-09-05 EP disclosed
US-20120208820-A1 DIAZABICYCLIC CENTRAL NERVOUS SYSTEM ACTIVE AGENTS SCHRIMPF MICHAEL R (US) 2012-08-16 US disclosed
US-8119635-B2 Diazabicyclic central nervous system active agents ABBOTT LABORATORIES (US) 2012-02-21 US disclosed
EP-2404923-A1 7-azabicyclo[2.2.1]heptane derivatives useful for promoting smoking cessation RESEARCH TRIANGLE INSTITUTE (US) 2012-01-11 EP disclosed
WO-1999038865-A1 8-AZABICYCLO(3.2.1)OCT-2-ENE DERIVATIVES AS PESTICIDES ZENECA LIMITED (GB) 1999-08-05 WO disclosed
WO-1998037082-A1 7a-HETEROCYCLE-SUBSTITUTED HEXAHYDRO-1H-PYRROLIZINE COMPOUNDS USEFUL IN CONTROLLING CHEMICAL SYNAPTIC TRANSMISSION ABBOTT LABORATORIES (US) 1998-08-27 WO disclosed
US-5733912-A NERVOUS SYSTEM DISORDERS IN NERVE CELLS ABBOTT LABORATORIES (US) 1998-03-31 US disclosed
EP-0136593-A3 NOVEL HALOPYRIDINES AND METHODS OF MAKING THE DOW CHEMICAL COMPANY (US) 1988-03-30 EP disclosed
US-4517368-A 2,3-Dichloro-5-iodopyridine and methods of making and using the same THE DOW CHEMICAL COMPANY (US) 1985-05-14 US disclosed
US-4517368-A 2,3-Dichloro-5-iodopyridine and methods of making and using the same THE DOW CHEMICAL COMPANY (US) 1985-05-14 US disclosed
US-4517368-A 2,3-Dichloro-5-iodopyridine and methods of making and using the same THE DOW CHEMICAL COMPANY (US) 1985-05-14 US disclosed
EP-0136593-A2 Novel halopyridines and methods of making THE DOW CHEMICAL COMPANY (US) 1985-04-10 EP disclosed
EP-0136593-A2 Novel halopyridines and methods of making THE DOW CHEMICAL COMPANY (US) 1985-04-10 EP disclosed